ArticleEndocrine, metabolic & immune disorders drug targets2026
EphrinB2 Ameliorates Renal Fibrosis by Inhibiting the TGF-β/Smad3 Signaling Pathway and the Inflammation Response
Cheng Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.